Skip to content

Clinical trials

Phase 2 Eye Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eye Diseases Phase: Phase 2 Country / region: United Kingdom Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20121
20131
20192
20201
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gyroscope Therapeutics Limited2
Oraya Therapeutics, Inc.2
Adverum Biotechnologies, Inc.1
Alcon Research1
Amgen1
Lassen Therapeutics Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eye Diseases9
Retinal Diseases4
Macular Degeneration3
Anetoderma2
Geographic Atrophy2
Graves Ophthalmopathy2
Retinal Degeneration2
Wet Macular Degeneration2
Arthritis1
Autoimmune Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.